Serum levels of interleukin-6 (IL-6), interleukin-18 (IL-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation;Níveis séricos de interleucina-6 (IL-6), interleucina-18 (IL-18) e proteína C reativa (PCR) na síndrome coronariana aguda sem supradesnivelamento do ST em pacientes com diabete tipo 2

Arquivos Brasileiros de Cardiologia

Volumn 90, Issue 2, 2008, Pages

  Souza, José Roberto Matos ^a,b   Oliveira, Romulo Tadeu ^a   Blotta, Maria Heloisa S L ^a   Coelho, Otávio Rizzi ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Coronary arteriosclerosis; Diabetes mellitus; Interleukin 18; Interleukin 6

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 18; INTERLEUKIN 6;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-18; INTERLEUKIN-6; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; STATISTICS, NONPARAMETRIC;

EID: 42049106004     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2008000200004     Document Type: Article

References (19)

1. Libby P; Molecular bases of the acute coronary syndromes. Circulation, 1995: 91:2844-2850.
2. Aronson D, Rayfield EJ. Diabetes and obesity. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven; 1996:327-359.
3. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-2581.
4. ROSS R; Atherosclerosis: an inflammatory disease. N Engl J Med, 1999; 340:115-126.
5. Okamura H, Tsutsui H, Kashiwamura S, et al. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol. . 1998; 70: 281-312.
6. Fantuzzi G, Reed DA, Dinarello CA. IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. J Clin Invest. 1999; 104: 761-767.
7. Sakkinen P, Abbott RD, Curb JD, et al. C-reactive protein and myocardial infarction. J Clin Epidemiol. 2002; 55: 445-451
8. Katherine E, et al. Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans. Circulation. 2002;106:2067-2072
9. Biasucci L, et al; Elevated Levels of Interleukin-6 in Unstable Angina. Circulation. 1996;94:874-877
10. Ridker PM, et al; C-Reactive Protein and Other markers of Inflammation in the Prediction of Cardiovascular Disease in Women. N Engl J Med, 2000; 342:836-43.
11. Schönbeck U., Libby P . Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents? Circulation, Jun 2004; 109: II-18-II-26.
12. Yudkin JS et al, High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease. Diabetes Care. 1999 Feb;22(2):363-4.
13. Festa A, et al. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int. 2000 Oct;58(4):1703-10.
14. Kanemaki T et al, Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology. 1998 May;27(5):1296-303
15. Moreno PR, et al;Coronary Composition and Macrophage Infiltration in Atherectomy Specimens From Patients With Diabetes Mellitus. Circulation, 2000;102:2180
16. Verma S, Kuliszewski MA, Mickle DAG, et al; C-reative protein attenuates endothelial progenitor cell survival and differentiation. Can J Cardiol. 2002;18:325
17. Verma S, Li S, Badiwala MV, Weisel RD, et al.Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein. Circulation 105: 1890-1896 2003.
18. Santos WB, Mesquita ET, Vieira RM, Olej B, et al. Proteína-C- reativa e doença cardiovascular Arq Bras Cardiol 2003; 80: 452-6.
19. Duarte ER, Pellanda LC E Portal VL. Perfil Inflamatório, Metabólico e Lipídico na Síndrome Isquêmica Aguda: Relação com Eventos Intra e Pós-Hospitalares. Arq Brás Cardiol 2005; 84: 122-9.